This is a press release by Reddy Netherlands B.V. (the "Offeror"), a wholly owned subsidiary of Dr. Reddy's Laboratories Ltd. ("Dr. Reddy's"), and Dr. Reddy's pursuant to Section 13 paragraph 1 of the Dutch Public Takeover Decree (Besluit openbare biedingen Wft, the "Decree") in connection with the recommended public offer (the "Offer") by the Offeror for all the issued and outstanding ordinary shares (the "Shares") in the capital of OctoPlus N.V. ("OctoPlus"or the "Company"). This press release does not constitute, or form part of, an offer or any solicitation of an offer, to acquire or subscribe or sell any securities in OctoPlus. The Offer is only made by means of the offer memorandum published on 13 December 2012 (the "Offer Memorandum"). This announcement is not for release, publication, dissemination, or distribution, in whole or in part, in or into Canada and Japan. Capitalised terms not defined in this press release shall have the meaning given thereto in the Offer Memorandum.

Hyderabad/Amsterdam, 17 December 2012 - With reference to the joint press release of the Offeror and OctoPlus (Euronext Amsterdam: OCTO) of 13 December 2012 relating to the Offer, the Offeror announces that it has acquired 182,588 Shares in the course of today at a volume weighed average price of EUR 0.52 per Share, a minimum price of EUR 0.52 per Share and a maximum price of EUR 0.52 per Share.

Together with the irrevocable undertakings received from the Committed Shareholders[1] and certain members of the Boards, this results in the following positions:
Number of Shares Percentage of Shares

Shares owned prior to today's acquisitions 7,496,484 14.2%

Shares acquired on 17 December 2012 182,588 0.3%

Total Shares owned on 17 December 2012 7,679,072 14.6%

Shares committed by Committed Shareholders 33,448,839 63.5%

Total Shares owned and committed 41,127,911 78.1%

[1] As indicated in the joint press release of 13 December 2012 and the Offer Memorandum, the irrevocable undertakings of the Committed Shareholders are subject to customary terms and conditions.

reactie XEA.nl
Dit geeft geen blijkt van eigen zekerheid in het deal. Daarom kopen ze ter beurze en straks een hogere bieding? Het zou ons niets verbazen., dan komt EUR 0,57 ct uit de bus.